Safety summary
Hazards: Potentially carcinogenic, based on safrole and methyleugenol content; psychotropic in high doses.
Contraindications: None known.
Maximum dermal use: 5%

Safety advice
It's recommened that a dermal maximum of 5% based on 0.5% safrole and 0.2% methyleugenol content.

Tisserand, R., & Young, R. (2014). Essential Oil Safety: Second edition

General 
Some essential oils may cause photosensitivity to the skin-Use diluted in Jojoba or other complete carrier oil.

Do not ingest essential oils.

Do not apply to eyes, sensitive areas or mucous membranes.

The information on this website is not intended to be used in the diagnosis, treatment or mitigation of any physical or mental illness. Ahimsa Oils offer no advice or recommendations only general information. No therapeutic claims are made within.

Pregnant women, nursing mothers and children should not use essential oils without first consulting an appropriately trained healthcare practitioner.

The statements on this website have not been evaluated by the TGA. David Bosley however worked for a long period however in consultation with the TGA to ensure correct labelling with reference to the Ahimsa Oil product range.